We are live on ! Find out more
SC

Scholtz & Company Portfolio holdings

AUM $200M
1-Year Est. Return 12.67%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+12.67%
3 Year Est. Return
+89.15%
5 Year Est. Return
+104.79%
10 Year Est. Return
+863.86%
AUM
$141M
AUM Growth
+$1.24M
Cap. Flow
+$1.1M
Cap. Flow %
0.78%
Top 10 Hldgs %
65.29%
Holding
52
New
6
Increased
8
Reduced
31
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 17.78%
3 Consumer Discretionary 16.97%
4 Industrials 15.55%
5 Financials 11.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKYX icon
51
SKYX Platforms
SKYX
$179M
-15,000
Closed -$41K
XLE icon
52
State Street Energy Select Sector SPDR ETF
XLE
$43.3B
-31,850
Closed -$1.48M

Similar funds

Scholtz & Company's Q4 2022 Portfolio in Review

As of Q4 2022, Scholtz & Company held 52 positions worth $141M, up 0.89% from $140M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Scholtz & Company's Q4 2022 filing shows 6 new, 8 increased, 31 reduced and 7 closed positions. Its largest new stake was ProShares Short S&P500: 121,683 shares worth $7.8M. The largest sale was Lam Research, an estimated $1.69M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Scholtz & Company's largest Q4 2022 buy was ProShares Short S&P500: 121,683 shares worth $7.8M.
  • Scholtz & Company added most to Northrop Grumman in Q4 2022, an estimated $900K increase.
  • Scholtz & Company's biggest Q4 2022 reduction was ProShares Short High Yield, cutting an estimated $1.31M.
  • Scholtz & Company fully exited Lam Research in Q4 2022, selling an estimated $1.69M.
  • Scholtz & Company's ten largest holdings make up 65% of its $141M portfolio in Q4 2022.
  • Scholtz & Company opened 6 new positions and closed 7 in Q4 2022.
  • Scholtz & Company's portfolio value rose 0.89% quarter-over-quarter to $141M.

Based on Scholtz & Company's 13F filing for Q4 2022, filed 14 Feb 2023.